Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission–experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen, CD Schweighofer… - Leukemia, 2004 - nature.com
Patients with CLL responding to initial chemotherapy with fludarabine alone (F) or in
combination with cyclophosphamide (FC) were randomized for treatment with alemtuzumab …

[引用][C] Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission-experience on safety and efficacy within a randomized …

W CM - Leukemia, 2004 - cir.nii.ac.jp
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first
remission-experience on safety and efficacy within a randomized multicenter phase III trial of the …

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission-experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen, CD Schweighofer… - Leukemia, 2004 - go.gale.com
Patients with CLL responding to initial chemotherapy with fludarabine alone (F) or in
combination with cyclophosphamide (FC) were randomized for treatment with alemtuzumab …

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen, CD Schweighofer… - …, 2004 - pubmed.ncbi.nlm.nih.gov
Patients with CLL responding to initial chemotherapy with fludarabine alone (F) or in
combination with cyclophosphamide (FC) were randomized for treatment with alemtuzumab …

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen, CD Schweighofer… - 2004 - mediatum.ub.tum.de
Patients with CLL responding to initial chemotherapy with fludarabine alone (F) or in
combination with cyclophosphamide (FC) were randomized for treatment with alemtuzumab …

[PDF][PDF] Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission–experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen, CD Schweighofer… - Leukemia, 2004 - researchgate.net
Patients with CLL responding to initial chemotherapy with fludarabine alone (F) or in
combination with cyclophosphamide (FC) were randomized for treatment with alemtuzumab …

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen, CD Schweighofer… - Leukemia, 2004 - europepmc.org
Patients with CLL responding to initial chemotherapy with fludarabine alone (F) or in
combination with cyclophosphamide (FC) were randomized for treatment with alemtuzumab …

[PDF][PDF] Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission–experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen, CD Schweighofer… - Leukemia, 2004 - academia.edu
Patients with CLL responding to initial chemotherapy with fludarabine alone (F) or in
combination with cyclophosphamide (FC) were randomized for treatment with alemtuzumab …

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission-experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen… - Leukemia …, 2004 - search.ebscohost.com
Patients with CLL responding to initial chemotherapy with fludarabine alone (F) or in
combination with cyclophosphamide (FC) were randomized for treatment with alemtuzumab …

[引用][C] Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission-experience on safety and efficacy within a randomized …

CM Wendtner, M Ritgen, CD Schweighofer… - …, 2004 - Nature Publishing Group